• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Advertisement
  • Home
  • Economy
  • Foreign Affairs
  • Science & Tech
  • Environment
  • Law & Policy
  • History
No Result
View All Result
  • Home
  • Economy
  • Foreign Affairs
  • Science & Tech
  • Environment
  • Law & Policy
  • History
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Society

 COVID-19 Treatment

June 26, 2020
in Society
Reading Time: 2min read
0
18
VIEWS
Share on TelegramShare on Facebook

Since COVID-19 is a novel virus, there have been continuous efforts by the various health agencies to undertake trials of various drugs to find efficacy, safety of those. It has been work in progress, with scientists getting better understanding with greater experimentation.

Dexamethasone trial

  • Preliminary findings shared with WHO have shown that Dexamethasone, a corticosteroid (which closely mimic cortisol, the hormone naturally produced by the adrenal glands in humans), can be lifesaving for patients who are critically ill with COVID-19.
  • For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth.
  • The benefit however was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease.
  • Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers.
  • It reduces the production of the chemicals that cause inflammation and also reduces the activity of the immune system by affecting the way white blood cells function.

Umifenovir Trial

  • The Central Drug Research Institute (CDRI), Lucknow, a constituent lab of the CSIR, has received permission for carrying out Phase III trials for the use of Umifenovir against COVID-19. It is found that the drug has a good safety profile and acts by preventing entry of the virus into human cells and also by priming the immune system.
  • Umifenovir is mainly used for the treatment of influenza. CSIR-CDRI has developed the process technology for Umifenovir and licensed the process technology for manufacturing and marketing the drug to Medizest Pharmaceuticals.

Favipiravir Trial

  • Glenmark Pharmaceuticals has received an approval from India’s drugs regulator to make and sell oral antiviral drug favipiravir for treating mild-to-moderate Covid-19 patients in the country.
  • Favipiravir is an antiviral drug and is also being used to treat new influenza viruses in Japan.

 

 

 

Tags: Prelims

Related Posts

Gandhian Paradigm of Indian Villages

Gandhian Paradigm of Indian Villages

January 16, 2021
Invisible Disabilities

Invisible Disabilities

January 15, 2021
Twin Track Approach Disability

Twin Track Approach Disability

January 15, 2021
Makar sankranti and harvest festivals across India

Makar sankranti and harvest festivals across India

January 14, 2021
Tapas BH 201 and SWIFT UAV

Tapas BH 201 and SWIFT UAV

January 11, 2021
Mahila Shakti Kendra Scheme

Mahila Shakti Kendra Scheme

January 9, 2021
Gandagi Mukt Bharat Campaign

Gandagi Mukt Bharat Campaign

January 9, 2021
RMNCAH +N

RMNCAH +N

January 8, 2021
Safe city project

Safe city project

January 8, 2021
Longitudinal Ageing Study of India (LASI) 

Longitudinal Ageing Study of India (LASI) 

January 7, 2021
Please login to join discussion

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society

Browse by Tags

AIR Big Picture Down to Earth GS-1 GS-2 GS-3 GS-4 Kurukshetra Mains News Paper PIB Prelims RSTV Spotlight on AIR Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society

Browse by Tag

AIR Big Picture Down to Earth GS-1 GS-2 GS-3 GS-4 Kurukshetra Mains News Paper PIB Prelims RSTV Spotlight on AIR Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • Prelims Snippets
  • Mains Articles
  • Economy
  • Society
  • Foreign Affairs
  • Science & Tech
  • Environment
  • Agriculture
  • History
  • Law & Policy
  • Security
  • Course Portal
  • Prelims Test Portal
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In